The growth in the heart closure devices market from 2024-2030 is mainly driven by several factors: the rising incidence of congenital heart defects, increased use of MRI procedures, greater awareness ...

CHICAGO, Nov 15 (Reuters) - NMT Medical Inc's catheter system that seals a hole in the heart worked no better than drugs to prevent stroke in a study, suggesting physicians perform too many closure ...

The 45-day post-implantation results support use of a next-generation device in people with atrial fibrillation, but caution is advised until longer-term results are available.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Rates of patency and device-related thrombus were ...

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation The trial met the primary safety ...

CINCINNATI (WKRC) - Breakthrough technology is transforming the lives of local heart failure patients, offering new hope and improved quality of life. The TriHealth Heart and Vascular Institute is at ...

A device smaller than a quarter is giving heart patients a new lease on life. The Watchman device is implanted in the heart to prevent blood clots from forming without the need of blood thinners. This ...

Johnson & Johnson MedTech has strengthened its cardiac treatment offerings with the $400 million acquisition of Laminar Inc., a private medical device company headquartered in Santa Rosa, Calif. The ...

A patent foramen ovale (PFO) is a hole in the heart that doesn’t close as expected after birth. Before a baby is born, they have a hole between the left and right sides of their heart. This hole, ...